4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001522780-25-000008
Director sold 2,136 shares at an average $30.22 ($64,541)
- Director acquired 4,317 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kaye Edward M. MD · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-01 | Exercise or conversion : show line 1 in the form | +4,317 | 53,441 | D | ||
| 2025-12-02 | Sale : show line 2 in the form | −661 | $29.56 | $19,540 | 52,780 | D |
| 2025-12-02 | Sale : show line 3 in the form | −405 | $30.14 | $12,207 | 52,375 | D |
| 2025-12-03 | Sale : show line 4 in the form | −419 | $30.34 | $12,712 | 51,956 | D |
| 2025-12-03 | Sale : show line 5 in the form | −651 | $30.85 | $20,082 | 51,305 | D |
| Open-market sales · 2,136 sh · avg $30.22 · $64,541 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-01 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −4,317 | 0 | D |
Loading xslF345X05/form4-12042025_011205.xml…